On March 21, the Court of Appeals for the Federal Circuit held in a precedential opinion that legal fees incurred by generic drug companies in defending against patent infringement suits brought under the Hatch-Waxman Act...more
3/26/2025
/ Abbreviated New Drug Application (ANDA) ,
Food and Drug Administration (FDA) ,
Generic Drugs ,
Hatch-Waxman ,
Internal Revenue Code (IRC) ,
IRS ,
Litigation Fees & Costs ,
Patent Infringement ,
Patent Litigation ,
Pharmaceutical Industry ,
Precedential Opinion ,
Tax Deductions
On February 26, 2025, the US Supreme Court issued a unanimous decision limiting the scope of an award of the “defendant’s profits” in trademark infringement suits under the Lanham Act, 15 U.S.C. §1117(a), to only those...more
3/4/2025
/ Affiliates ,
Appeals ,
Calculation of Damages ,
Corporate Misconduct ,
Dewberry Group Inc v Dewberry Engineers Inc ,
Disgorgement ,
Intellectual Property Litigation ,
Lanham Act ,
SCOTUS ,
Trademark Infringement ,
Unfair Competition
Goodwin’s Appellate Litigation practice has argued before the U.S. Supreme Court, federal courts of appeals and state appellate courts, representing clients in matters ranging from First Amendment rights to governmental...more
11/13/2020
/ Appeals ,
Class Action ,
Coronavirus/COVID-19 ,
Deportation ,
Employee Retirement Income Security Act (ERISA) ,
First Amendment ,
Free Speech ,
Immigrants ,
Intellectual Property Litigation ,
Intellectual Property Protection ,
Judicial Appointments ,
Patent Trial and Appeal Board ,
Patents ,
Removal Proceedings
On May 7, 2018, the Massachusetts Supreme Judicial Court (SJC) issued its long-awaited decision in Nguyen v. Massachusetts Institute of Technology. The case involved a 25-year-old MIT graduate student, Han Nguyen, who took...more